305-468-3314
3650 NW 82nd Avenue, Suite 502, Miami, FL 33166

Kidney cancer is a complex disease that affects thousands of people around the world, particularly in New York. Patients are increasingly seeking the latest techniques for kidney cancer treatment. Early detection of kidney cancer is crucial, as it can significantly improve survival rates after diagnosis. In New York, patients benefit from a combination of modern procedures and personalized care that addresses the challenges associated with kidney cancer diagnosis.
Kidney cancer, also known as renal cancer, typically originates in the cells of the kidneys. Renal cell carcinoma is the most common type of kidney cancer. While both men and women can develop this disease, it is diagnosed more frequently in men. In the early stages, kidney cancer may not present any symptoms. However, as the disease progresses, some symptoms may emerge, including blood in the urine, persistent lower back pain, weight loss, fatigue, and fever. Early detection is vital for effective treatment and improved survival rates.
In New York, cutting-edge kidney cancer treatment options are available, including surgery, targeted therapy, immunotherapy, and radiation therapy. The treatment will depend on various factors, including the stage of cancer, the patient’s overall health, and the size of the tumor.
The primary and standard treatment for kidney cancer is surgery. When the tumor is localized to the kidney and has not spread to other parts of the body, then a surgical procedure, including radical nephrectomy (removal of the entire kidney), is performed. When the tumor in the kidney is small, a partial nephrectomy is performed, where only the tumor is removed by preserving the rest of the kidney.
When the cancer has spread to surrounding lymph nodes or organs, advanced surgery may be essential to remove metastases. With advanced robotic and laparoscopic surgery options, such as robotic nephrectomy, an experienced oncologist like Dr. Shirin Razdan can offer less invasive procedures, quicker recovery times, and reduced risks of complications.
Targeted therapy targets the cancer cells while minimizing the damage to healthy cells. Patients in New York have access to the latest FDA-approved targeted therapies. Some drugs, including sunitinib, pazopanib, and axitinib, are used, and these medications can block the blood supply to the tumor, helping to slow or stop its growth. Targeted therapies can offer a less invasive alternative to surgery and traditional chemotherapy. These types of treatment are often used when surgery is not an option or when the cancer has spread to other organs of the body.
Immunotherapy is a highly promising treatment for kidney cancer, where drugs like nivolumab and ipilimumab are used to boost the immune response against kidney cancer. This type of treatment is effective for patients who have experienced recurrent kidney cancer after initial treatment or with metastatic kidney cancer.
Radiation therapy is not a primary treatment for kidney cancer, but it can be used in certain situations. This type of treatment is performed when the cancer has spread to other parts of the body, especially to the bones or brain. This treatment is also utilized to help alleviate symptoms, including pain caused by metastases.
Chemotherapy is used in rare cases and is not as effective in treating this type of cancer in comparison to other cancers. Chemotherapy is considered if the cancer has spread extensively or in conjunction with other treatment modalities.
Dr. Shirin Razdan is a widely renowned oncologist practicing in Miami and serving patients in New York, as she specializes in the treatment of kidney cancer. As a leader in the urological field, she is recognized for her expertise in both traditional and innovative treatments. She, along with her team, ensures that each patient receives the most comprehensive and personalized care. Her approach is patient-centric, focusing on both treating the cancer and the patient’s overall well-being. She takes the time to understand the complexity of your condition, explains the available treatment options, and answers all your questions. After this, she, along with her team of experts, will develop a personalized treatment plan tailored to your unique needs, preferences, and overall health.
She is dedicated to offering cutting-edge treatment for kidney cancer that allows her to provide advanced therapies, including immunotherapies and targeted therapy. She helps patients achieve better outcomes by providing the best possible care.

The treatment process for kidney cancer begins with a consultation with a specialist, Dr. Shirin Razdan, who will create a personalized treatment plan. This plan may include a variety of treatment options such as surgery, targeted therapies, and immunotherapy. Patients are closely monitored throughout their treatment and receive emotional and psychological support. The main goal of kidney cancer treatment is not only to eliminate the cancer but also to help patients return to their normal daily activities. Ongoing monitoring and regular follow-up visits are essential to ensure the long-term success of the treatment.
Answer. Surgery is considered the most common treatment for kidney cancer. Radical nephrectomy or partial nephrectomy are the standard procedures to remove the tumor from the kidneys.
Answer. Yes, immunotherapy can be an effective treatment for kidney cancer, especially for metastatic or recurrent cancer. Immunotherapy can stimulate the body’s immune system to attack cancer cells.
Answer. Yes, targeted therapy can be used to treat kidney cancer that targets specific cancer cell mechanisms to slow or stop tumor growth with fewer side effects than traditional chemotherapy.
Answer. Survival rates from kidney cancer depend on different factors, including cancer stage, type, and overall health. With early detection and treatment, the survival rates can be increased, especially with the advanced care options available in New York.
Answer. A detailed medical history and physical examination play a crucial role in the diagnosis of kidney cancer. Imaging tests, including ultrasound, CT scans, and MRI scans, are used to assess the size and location of the tumor. A biopsy can be performed to confirm the presence of cancerous cells in the kidneys.
Answer. Several factors increase the risk of developing kidney cancer, including smoking, obesity, high blood pressure, and a family history of kidney cancer. Those who have chronic kidney disease or have undergone dialysis are at a higher risk. By understanding your individual risk, it becomes easy to detect and manage kidney cancer.
Dr. Shirin Razdan is the director of the robotic surgery department at the Comprehensive Urological Surgery Institute in Miami, Florida. She is one of the leading and world renowned robotic surgeons in the United States who completed her medical education from Icahn School of Medicine at Mount Sinai Hospital, New York and has undergone subspecialty training in Urologic Oncology and Robotic Surgery.
© 2025 Miami Robotic Surgery. All rights reserved.